New Fashion Design for α-Cyclopentyl-DL-Mandelic Acid - 3-Bromo-4-Fluorobenzaldehyde CAS 77771-02-9 High Quality – Ruifu

Short Description:


Product Detail

Related Products

Product Tags

Related Video

Feedback (2)

, , ,
New Fashion Design for α-Cyclopentyl-DL-Mandelic Acid - 3-Bromo-4-Fluorobenzaldehyde CAS 77771-02-9 High Quality – Ruifu Detail:

Manufacturer with High Purity and Stable Quality
Chemical Name: 3-Bromo-4-Fluorobenzaldehyde
CAS: 77771-02-9
High Quality, Commercialized Production

Chemical Name 3-Bromo-4-Fluorobenzaldehyde
CAS Number 77771-02-9
CAT Number RF-PI320
Stock Status In Stock, Production Scale Up to Tons
Molecular Formula C7H4BrFO
Molecular Weight 203.01
Melting Point 31.0~33.0℃(lit.)
Boiling Point 138.0~139.0℃/2.5 mmHg (lit.)
Density 1.6698
Refractive Index 1.574
Solubility Insoluble in Water
Brand Ruifu Chemical
Item Specifications
Appearance White to Off-White Powder
Identification IR Sample Spectrum corresponds to that of reference standard
Identification HPLC The retention time of the major peak of the sample solution corresponds to that of the standard solution
Related Substances
20H01 ≤0.10%
20H02 ≤0.10%
20H04 ≤0.10%
20HIb ≤0.10%
20H21 ≤0.10%
Any Unspecified Impurity ≤0.10%
Total Unspecified Impurities ≤0.30%
Total Impurities ≤0.50%
Residual Solvents
N-Heptane ≤5000ppm
Ethanol ≤5000ppm
Isopropyl Acetate ≤5000ppm
Acetonitrile ≤410ppm
Methylene Dichloride ≤600ppm
Acetone ≤5000ppm
Isopropanol ≤5000ppm
Water Content (K.F) ≤0.50%
Loss on Drying ≤1.0%
Residue on Ignition ≤0.10%
Optical Rotation -7.5° to -9.5° (C=0.5, Methanol)
Heavy Metals ≤10ppm
Purity / Analysis Method ≥99.5% (230nm)
Assay / Analysis Method 98.0%~102.0% (HPLC on dried basis)
Shelf Life 24 Months
Test Standard Enterprise Standard
Usage API, Molnupiravir (EIDD-2801) COVID-19 Inhibitor

Package: Bottle, Aluminum foil bag, Cardboard drum, 25kg/Drum, or according to customer’s requirement.

Storage Condition: Store in sealed containers at cool and dry place; Protect from light, moisture and pest infestation.

1

Molnupiravir (EIDD-2801, MK-4482) is an orally bioavailable prodrug of the ribonucleoside analog β-d-N4-hydroxycytidine (NHC; EIDD-1931) with broad-spectrum antiviral activity against SARS-CoV-2, MERS-CoV, SARS-CoV, and the causative agent of COVID-19. Molnupiravir is sold under the brand name Lagevrio and generically as emorivir. Molnupiravir has been shown to improve pulmonary function, decrease body weight loss and reduce the amount of virus in the lung. In addition to activity against coronaviruses, Molnupiravir, in laboratory studies, has demonstrated activity against seasonal and bird influenza, respiratory syncytial virus, chikungunya virus, Ebola virus, Venezuelan equine encephalitis virus, and Eastern equine encephalitis virus. Molnupiravir was originally developed to treat influenza at Emory University by the university’s drug innovation company, Drug Innovation Ventures at Emory (DRIVE), but was reportedly abandoned for mutagenicity concerns. It was then acquired by Miami-based company Ridgeback Biotherapeutics, which later partnered with Merck & Co. to develop the drug further. Molnupiravir was approved for medical use in the United Kingdom in November 2021.


Product detail pictures:

New Fashion Design for α-Cyclopentyl-DL-Mandelic Acid - 3-Bromo-4-Fluorobenzaldehyde CAS 77771-02-9 High Quality – Ruifu detail pictures


Related Product Guide:

New Fashion Design for α-Cyclopentyl-DL-Mandelic Acid - 3-Bromo-4-Fluorobenzaldehyde CAS 77771-02-9 High Quality – Ruifu , The product will supply to all over the world, such as: , , ,

  • 5 Stars By from -

    5 Stars By from -
    Write your message here and send it to us